Imagine a world where a lung cancer diagnosis no longer feels like a death sentence, but rather a challenge that can be managed with the right tools and support. For too long, this disease has carried a heavy burden of fear and stigma, often seen as an unstoppable force due to its high mortality
In cancer trials where survival curves dominate headlines yet leave the lived experience in the margins, a new consensus promises to pull patient voices into the center of decision-making by standardizing how those voices are captured, analyzed, and reported. Patient-reported outcomes (PROs) have
Across the human genome, a narrow slice at the very start of genes keeps leaving the same telltale mark—mutations that appear more often than expected and matter more than many once thought, compelling a rethink of how models, pipelines, and clinics treat these small but powerful stretches. Recent
Watching a single enzyme switch from a standstill to full sprint while decoding DNA inside a mammalian cell would have sounded like science fiction not long ago, yet that leap just became a measurable reality thanks to a single-molecule transcription platform that links factor binding to RNA
In this conversation, we explore why metastatic recurrence strikes nearly one in ten adolescents and young adults (AYAs) who initially present with non-metastatic cancers, how statewide data were linked to reveal patterns across tumor types, and what these findings mean for surveillance, equity,
Imagine starting each day with a steaming cup of tea, a ritual cherished by millions worldwide for its soothing aroma and perceived wellness perks. Yet, beneath this comforting habit lies a complex debate: Is tea truly a health elixir, or does it harbor hidden risks? This roundup dives into the
